The expanding role of circulating tumor DNA in resectable non-small cell lung cancer

被引：1
|
作者：
Morgensztern, Daniel [1 ]
机构：
[1] Washington Univ, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA
来源：
CANCER | 2024年 / 130卷 / 10期
关键词：
PLUS CHEMOTHERAPY; PHASE-III; MRD PLUS; DURVALUMAB; NSCLC;
D O I：
10.1002/cncr.35268
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite treatment with curative intent, many patients with non-small cell lung cancer develop tumor relapse. The detection of minimal residual disease with circulating tumor DNA may allow for a more personalized treatment, which may potentially allow patients with a high risk for relapse to receive more aggressive therapy and those with a low risk for relapse to avoid overtreatment.
引用
收藏
页码：1730 / 1732
页数：3
相关论文
共 50 条
  • [1] Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer
    Abbosh, Chris
    Hodgson, Darren
    Doherty, Gary J.
    Gale, Davina
    Black, James R. M.
    Horn, Leora
    Reis-Filho, Jorge S.
    Swanton, Charles
    TRENDS IN CANCER, 2024, 10 (07) : 643 - 654
  • [2] Role of circulating-tumor DNA analysis in non-small cell lung cancer
    Jiang, Tao
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2015, 90 (02) : 128 - 134
  • [3] Commentary: Circulating tumor DNA in resectable non-small cell lung cancer: Emerging canary in the coal mine
    Sachdeva, Uma M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (05):
  • [4] Detection and application of circulating tumor cell and circulating tumor DNA in the non-small cell lung cancer
    Zhang, Yuting
    Zheng, Hongmei
    Zhan, Yuting
    Long, Mengping
    Liu, Sile
    Lu, Junmi
    Zang, Hongjing
    Fan, Songqing
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (12): : 2377 - 2386
  • [5] Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
    Yang, Jialiang
    Hui, Yan
    Zhang, Yanxiang
    Zhang, Minghui
    Ji, Binbin
    Tian, Geng
    Guo, Yangqiang
    Tang, Min
    Li, Lianxing
    Guo, Bella
    Ma, Tonghui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Circulating tumor DNA testing in advanced non-small cell lung cancer
    Moding, Everett J.
    Diehn, Maximilian
    Wakelee, Heather A.
    LUNG CANCER, 2018, 119 : 42 - 47
  • [7] Circulating Tumor DNA as a Biomarker in Oligometastatic Non-small Cell Lung Cancer
    Lebow, E. S.
    Murciano-Goroff, Y.
    Razavi, P.
    Reis-Filho, J. S.
    Flynn, J.
    Zhang, Z.
    Tu, H. Y.
    Bertucci, C.
    Lim, L. P.
    Li, M.
    Drilon, A.
    Riely, G.
    Rudin, C. M.
    Jones, D.
    Yang, T. J.
    Rimner, A.
    Arcila, M. E.
    Isbell, J.
    Li, B. T.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S174 - S174
  • [8] Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer
    Shields, Misty Dawn
    Chen, Kevin
    Dutcher, Giselle
    Patel, Ishika
    Pellini, Bruna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [9] Circulating tumor DNA analysis integrating tumor clonality detects minimal residual disease in resectable non-small cell lung cancer
    Yin, R.
    Wang, S.
    Wu, M.
    Li, M.
    Bao, H.
    Jiang, F.
    Wang, J.
    Wu, X.
    Shao, Y.
    Xu, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S932 - S932
  • [10] Serum tumor markers in resectable and non-resectable non-small cell lung cancer
    Nisman, B
    Heching, N
    Barak, V
    JOURNAL OF TUMOR MARKER ONCOLOGY, 2000, 15 (03): : 195 - 207
12345